Teva tightens Swiss franc tranche guidance on strong demand

Teva Pharmaceutical Industries, the Israeli generic drug company, revised guidance on its debut Swiss franc bond on Monday to 80bp over mid-swaps, from mid-swaps plus 85bp. The 6.5 year deal, maturing in 2018, is expected to be minimum Sfr250m ($221.46m) but already has an order book in excess of Sfr400m after opening on Monday morning. Pricing is expected this afternoon.

  • 02 Apr 2012

BNP Paribas, Credit Suisse and HSBC are leading the deal, which follows Teva launching its first non-dollar denominated bond on Thursday last week. That euro demoninated tranche, led by the same banks, raised €1bn in a sale that found exceptionally strong demand, with a €7bn order book.

The ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of International Emerging Market DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 20 Mar 2017
1 JPMorgan 17,834.38 72 10.56%
2 Citi 16,648.84 65 9.86%
3 HSBC 14,502.17 79 8.59%
4 Deutsche Bank 10,659.15 37 6.31%
5 Standard Chartered Bank 8,423.03 47 4.99%

Bookrunners of LatAm Emerging Market DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 14 Mar 2017
1 Citi 5,687.17 13 16.25%
2 JPMorgan 4,222.60 16 12.06%
3 HSBC 3,485.94 6 9.96%
4 Deutsche Bank 2,957.20 4 8.45%
5 Morgan Stanley 2,629.01 9 7.51%

Bookrunners of CEEMEA International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 JPMorgan 7,610.36 27 13.98%
2 Citi 6,685.06 20 12.28%
3 HSBC 4,539.92 22 8.34%
4 Deutsche Bank 3,547.08 9 6.52%
5 Standard Chartered Bank 3,538.08 13 6.50%

EMEA M&A Revenue

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 02 May 2016
1 JPMorgan 195.08 50 10.55%
2 Goldman Sachs 162.26 37 8.77%
3 Morgan Stanley 141.22 46 7.64%
4 Bank of America Merrill Lynch 114.20 33 6.18%
5 Citi 95.36 35 5.16%

Bookrunners of Central and Eastern Europe: Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 Bank of America Merrill Lynch 390.53 2 13.27%
2 UniCredit 321.12 2 10.91%
3 Raiffeisen Bank International AG 206.29 2 7.01%
3 ING 206.29 2 7.01%
3 Citi 206.29 2 7.01%

Bookrunners of India DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 08 Mar 2017
1 AXIS Bank 1,318.15 23 14.27%
2 Trust Investment Advisors 1,079.75 29 11.69%
3 ICICI Bank 773.60 21 8.37%
4 Citi 601.55 5 6.51%
5 Standard Chartered Bank 591.66 6 6.41%